Kyndi® Appoints Dan Gartung as Chief Technology Officer

Share Article

Gartung Brings Over Three Decades of Experience Leading Engineering and Technology Teams

Kyndi®, the leading Explainable AI software solution, today announced the promotion of Dan Gartung to Chief Technology Officer. He leads the engineering and applied research teams.

Gartung’s transition from Director of Machine Learning to Chief Technology Officer recognizes Kyndi’s continued success using its Artificial Intelligence platform to solve real customer problems by analyzing long form text in the life sciences and government verticals. Prior to Kyndi, he was VP of Data Science at Vocus. He has been a co-founder and technology leader at no fewer than five successful startups. Gartung holds a Bachelor of Science in Business Administration from the University of California, Berkeley Haas School of Business.

"We are excited to appoint Dan as Kyndi's Chief Technology Officer," said Kyndi Founder & CEO Ryan Welsh. "His vision and experience will be invaluable as we grow our engineering team and deliver on Kyndi's mission of empowering people to do their most meaningful work."

"I am incredibly optimistic about the direction of Kyndi and the potential for our technology to fulfill crucial market needs," said Gartung. "I look forward to contributing to Kyndi's continued success as we build artificial intelligence solutions that solve real-world problems."

About Kyndi®

Kyndi is an artificial intelligence company building the first Explainable AI platform for government and life sciences. Our product exists because organizations cannot use “black box” machine learning when they are required to explain the reason for any decision. Founded in 2014, the company was named to the CB Insights AI 100 for 2018, which includes the most promising 100 private companies working on groundbreaking artificial intelligence technology, and was named an IDC Innovator: AI Software Platforms, 2018. Based in Silicon Valley, Kyndi is backed by leading venture investors. Customers include Fortune 500 pharmaceutical companies and government agencies. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Amy Guarino
+1 (650) 437-7440
Email >
Visit website